Nuveen’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Sell
87,522
-215,079
-71% -$4.31M ﹤0.01% 2364
2025
Q4
$7.09M Sell
302,601
-204,930
-40% -$4.45M ﹤0.01% 1753
2025
Q3
$10.1M Buy
507,531
+424,385
+510% +$7.62M ﹤0.01% 1548
2025
Q2
$1.14M Sell
83,146
-9,811
-11% -$94.1K ﹤0.01% 2545
2025
Q1
$1.03M Hold
92,957
﹤0.01% 2635
2024
Q4
$990K Sell
92,957
-56,430
-38% -$676K ﹤0.01% 2716
2024
Q3
$1.9M Buy
149,387
+56,430
+61% +$838K ﹤0.01% 2437
2024
Q2
$1.56M Buy
92,957
+9,538
+11% +$136K ﹤0.01% 2504
2024
Q1
$1.25M Hold
83,419
﹤0.01% 2606
2023
Q4
$1.25M Buy
83,419
+19,785
+31% +$257K ﹤0.01% 2624
2023
Q3
$892K Buy
63,634
+2,172
+4% +$34.9K ﹤0.01% 2620
2023
Q2
$636K Buy
+61,462
New +$678K ﹤0.01% 2852
2022
Q2
Sell
-94,660
Closed -$854K 3487
2022
Q1
$854K Buy
94,660
+908
+1% +$7.08K ﹤0.01% 2867
2021
Q4
$906K Sell
93,752
-6,564
-7% -$92.5K ﹤0.01% 2890
2021
Q3
$1.67M Buy
100,316
+3,716
+4% +$58.9K ﹤0.01% 2756
2021
Q2
$1.48M Sell
96,600
-6,054
-6% -$109K ﹤0.01% 2843
2021
Q1
$2M Sell
102,654
-95,036
-48% -$2.02M ﹤0.01% 2622
2020
Q4
$3.56M Sell
197,690
-42,558
-18% -$892K ﹤0.01% 2240
2020
Q3
$4.63M Sell
240,248
-96,901
-29% -$2.19M ﹤0.01% 1957
2020
Q2
$8.81M Buy
337,149
+66,316
+24% +$1.62M ﹤0.01% 1565
2020
Q1
$4.83M Buy
+270,833
New +$7.32M ﹤0.01% 1733
2019
Q4
Sell
-45,444
Closed -$1.08M 3270
2019
Q3
$1.08M Buy
45,444
+2,618
+6% +$85.6K ﹤0.01% 2666
2019
Q2
$1.54M Buy
+42,826
New +$1.58M ﹤0.01% 2555

Other funds holding URGN